Second of Four Planned Modules Moves Rolling FDA Review Forward Advances Toward Targeted Completion of the Final Clinical ...
SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of ...
LOS ANGELES, May 07, 2026 (GLOBE NEWSWIRE)-- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and ...
Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announces the ...
ALPS Medical Breakthroughs ETF (SBIO) targets late-stage clinical biotech firms poised for FDA approval or acquisition, offering high-risk, high-reward exposure. SBIO surged 91% over the past year, ...
Medicine is entering a new era of breakthrough science, with innovations once considered out of reach now becoming reality. Researchers are developing therapies that target diseases in entirely new ...
A new experimental drug for pancreatic cancer, daraxonrasib, appears to have extended the lives of some patients with advanced disease by several months, according to clinical trial results out last ...
Many families have been affected by serious or chronic illness. Whether it is a parent confronting a cancer diagnosis, a grandparent losing ground to Alzheimer’s, a child learning to manage juvenile ...
From vaccines that eradicated deadly diseases to surgical techniques that make once-fatal operations routine, medicine's greatest breakthroughs have reshaped how long and how well we live. Each ...
The baby had congenital pulmonary airway malformation (CPAM), a rare condition in which abnormal lung tissue develops during pregnancy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results